SCHEMBL4355386

SCHEMBL4355386

O=C1N=C(NCc2ccc3c(c2)OCO3)S/C1=C\c1cccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
KMT2A Q03164 6/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
GLA P06280 1/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 5/20 0.44
LMNA P02545 4/20 0.44
GAA P10253 1/20 0.44
PDE5A O76074 1/20 0.44
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 2/20 0.41
AURKA O14965 2/20 0.41
RPS6KB1 P23443 2/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CREBBP Q92793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355388 1.00 KDM4E (0.47) KDM4EKMT2AMAPTALDH1A1HTT
SCHEMBL4350079 0.82 KMT2A (0.55) KDM4EKMT2AMAPTALDH1A1HTT
SCHEMBL4350081 0.82 KMT2A (0.55) KDM4EKMT2AMAPTALDH1A1HTT
SCHEMBL4873444 0.81 CLK4 (0.45) KMT2AALDH1A1POLBMEN1LMNA
SCHEMBL4348118 0.79 MAPT (0.49) KMT2AMAPTALDH1A1HTTGLA
SCHEMBL4348120 0.79 MAPT (0.49) KMT2AMAPTALDH1A1HTTGLA
SCHEMBL4355549 0.77 HPGD (0.43) ALDH1A1HPGDL3MBTL1FLT1KDR
SCHEMBL4355546 0.77 HPGD (0.43) ALDH1A1HPGDL3MBTL1FLT1KDR
SCHEMBL4351083 0.76 ALDH1A1 (0.42) KMT2AALDH1A1HTTMEN1LMNA
SCHEMBL4350119 0.75 HPGD (0.48) KMT2AMAPTALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 KDM4E 3224/4885KMT2A 3923/4885MAPT 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.